Browse > Article
http://dx.doi.org/10.20307/nps.2021.27.4.251

Inhibition of Interleukin-4 and β-Hexosaminidase Release in RBL-2H3 Cells by Compounds Isolated from Lobelia chinensis  

Kim, Tae Young (College of Pharmacy, Pusan National University)
Jo, Beom-Geun (College of Pharmacy, Pusan National University)
Park, No-Jun (Natural Products Research Institute, Korea Institute of Science and Technology)
Park, Young-Hun (College of Pharmacy, Pusan National University)
Kim, Su-Nam (Natural Products Research Institute, Korea Institute of Science and Technology)
Yang, Min Hye (College of Pharmacy, Pusan National University)
Publication Information
Natural Product Sciences / v.27, no.4, 2021 , pp. 251-256 More about this Journal
Abstract
Lobelia chinensis Lour. has commonly been used in traditional Chinese medicine for the treatment of antidote, diuretic, diarrhea, and inflammation. This study aimed to identify the active compounds in an aqueous extract of L. chinensis responsible for its anti-atopic effect in vitro using RBL-2H3 cells. A chemical investigation of secondary metabolites in an aqueous extract of L. chinensis led to the isolation of nine chemical constituents, which included the four marker compounds, and these were evaluated for their inhibitory effects on IL-4 mRNA expression and the release of β-hexosaminidase in propidium iodide-induced RBL-2H3 cells. We found diosmetin and fraxidin inhibited cellular IL-4 mRNA expression, and that diosmetin and 6,8-dimethoxycoumarin inhibited DNP-specific IgE-induced degranulation in these cells. Our study suggests that diosmetin, fraxidin, and 6,8-dimethoxycoumarin are potential candidates for the treatment of atopic diseases.
Keywords
Lobelia chinensis; Atopic dermatitis; IL-4; ${\beta}$-hexosaminidase;
Citations & Related Records
연도 인용수 순위
  • Reference
1 DAS, S.; MANDAL, S. K. Asian J. Pharm. Clin. Res. 2018, 11, 61-65.   DOI
2 McLeod, J. J.; Baker, B.; Ryan, J. J. Cytokine 2015, 75, 57-61.   DOI
3 May, R. D.; Fung, M. Cytokine 2015, 75, 89-116.   DOI
4 Matsuda, H.; Nakamura, S.; Yoshikawa, M. Chem. Pharm. Bull (Tokyo). 2016, 64, 96-103.   DOI
5 Sahid, M. N. A.; Kiyoi, T. J. Immunoassay Immunochem. 2020, 41, 778-816.   DOI
6 Zaitsu, M.; Narita, S. I.; Lambert, K. C.; Grady, J. J.; Estes, D. M.; Curran, E. M.; Brooks, E. G.; Watson, C. S.; Goldblum, R. M.; Midoro-Horiuti, T. Mol. Immunol. 2007, 44, 1977-1985.   DOI
7 Sit, N. W.; Chan, Y. S.; Chuah, B. L.; Cheng, R. J.; Leong, W. M.; Khoo, K. S. Southeast Asian J. Trop. Med. Public Health 2017, 48, 616-627.
8 Dastych, J.; Walczak-Drzewiecka, A.; Wyczolkowska, J.; Metcalfe, D. D. J. Allergy Clin. Immunol. 1999, 103, 1108-1114.   DOI
9 Wollenberg, A.; Oranje, A.; Deleuran, M.; Simon, D.; Szalai, Z.; Kunz, B.; Svensson, A.; Barbarot, S.; Von Kobyletzki, L.; Taieb, A.; de Bruin-Weller, M.; Werfel, T.; Trzeciak, M.; Vestergard, C.; Ring, J.; Darsow, U. J. Eur. Acad. Dermatol. Venereol. 2016, 30, 729-747.   DOI
10 De Bruyne, R.; Bogaert, D.; De Ruyck, N.; Lambrecht, B.; Van Winckel, M.; Gevaert, P.; Dullaers, M. Clin. Exp. Immunol. 2015, 180, 542-550.   DOI
11 Kuo, P. C.; Hwang, T. L.; Lin, Y. T.; Kuo, Y. C.; Leu, Y. L. Arch. Pharm. Res. 2011, 34, 715-722.   DOI
12 Mei-Wan, C.; Wen-Rong, C.; Zhang, J. M.; Long, X. Y.; Wang, Y. T. Chin. J. Nat. Med. 2014, 12, 103-107.   DOI
13 Yang, S.; Shen, T.; Zhao, L.; Li, C.; Zhang, Y.; Lou, H.; Ren, D. Fitoterapia 2014, 93, 168-174.   DOI
14 Lee, D. H.; Park, J. K.; Choi, J.; Jang, H.; Seol, J. W. Int. Immunopharmacol. 2020, 89, 107046.   DOI
15 Li, K. C.; Ho, Y. L.; Huang, G. J.; Chang, Y. S. Am. J. Chin. Med. 2015, 43, 269-287.   DOI
16 Hart, P. H. Immunol. Cell Biol. 2001, 79, 149-153.   DOI
17 Le Floc'h, A.; Allinne, J.; Nagashima, K.; Scott, G.; Birchard, D.; Asrat, S.; Bai, Y.; Lim, W. K.; Martin, J.; Huang, T.; Potocky, T. B.; Kim, J. H.; Rafique, A.; Papadopoulos, N. J.; Stahl, N.; Yancopoulos, G. D.; Murphy, A. J.; Sleeman, M. A.; Orengo, J. M. Allergy 2020, 75, 1188-1204.   DOI
18 Leung, D.Y. M.; Bieber, T. Lancet 2003, 361, 151-160.   DOI
19 Leung, D. Y. M.; Boguniewicz, M.; Howell, M. D.; Nomura, I.; Hamid, Q. A. J. Clin. Invest. 2004, 113, 651-657.   DOI
20 Yang, T. L. B.; Kim, B. S . J. Allergy Clin. Immunol. 2019, 144, 353-360.   DOI
21 DaVeiga, S. P. Allergy Asthma Proc. 2012, 33, 227-234.   DOI
22 Ong, P. Y.; Leung, D. Y. M. Curr. Allergy Asthma Rep. 2006, 6, 384-389.   DOI
23 Avgerinou, G.; Goules, A. V.; Stavropoulos, P. G.; Katsambas, A. D. Int. J. Dermatol. 2008, 47, 219-224.   DOI
24 Galli, S. J.; Tsai, M. Nat. Med. 2012, 18, 693-704.   DOI
25 Jang, S. I.; Kim, Y. J.; Lee, W. Y.; Kwak, K. C.; Baek, S. H.; Kwak, G. B.; Yun, Y. G.; Kwon, T. O.; Chung, H. T.; Chai, K. Y. Arch. Pharm. Res. 2005, 28, 203-208.   DOI
26 Buys, L. M. Am. Fam. Physician 2007, 75, 523-528.
27 Liu, F. T.; Goodarzi, H.; Chen, H. Y. Clin. Rev. Allergy Immunol. 2011, 41, 298-310.   DOI